Dimensional Fund Advisors’s Kyntra Bio KYNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,441
Closed -$1.61M 3493
2023
Q1
$1.61M Buy
+3,441
New +$1.82M ﹤0.01% 2792
2022
Q3
$1.12M Sell
3,441
-20,290
-85% -$6.53M ﹤0.01% 2856
2022
Q2
$6.27M Sell
23,731
-5,556
-19% -$1.42M ﹤0.01% 2386
2022
Q1
$8.8M Buy
29,287
+19,669
+205% +$6.86M ﹤0.01% 2350
2021
Q4
$3.39M Buy
9,618
+1,129
+13% +$352K ﹤0.01% 2690
2021
Q3
$2.17M Sell
8,489
-2,490
-23% -$882K ﹤0.01% 2834
2021
Q2
$7.31M Sell
10,979
-1,982
-15% -$1.14M ﹤0.01% 2482
2021
Q1
$11.2M Sell
12,961
-2,581
-17% -$2.75M ﹤0.01% 2276
2020
Q4
$14.4M Sell
15,542
-6,637
-30% -$6.98M 0.01% 2123
2020
Q3
$22.8M Sell
22,179
-804
-3% -$865K 0.01% 1772
2020
Q2
$23.3M Buy
22,983
+2,161
+10% +$2.01M 0.01% 1793
2020
Q1
$18.1M Buy
20,822
+3,714
+22% +$3.69M 0.01% 1812
2019
Q4
$18.3M Buy
17,108
+3,974
+30% +$4.06M 0.01% 2083
2019
Q3
$12.1M Buy
13,134
+10,521
+403% +$11.6M ﹤0.01% 2263
2019
Q2
$2.95M Sell
2,613
-4,302
-62% -$4.71M ﹤0.01% 2795
2019
Q1
$9.4M Buy
6,915
+666
+11% +$903K ﹤0.01% 2430
2018
Q4
$7.23M Buy
6,249
+376
+6% +$423K ﹤0.01% 2479
2018
Q3
$8.92M Buy
5,873
+2,562
+77% +$3.95M ﹤0.01% 2487
2018
Q2
$5.18M Sell
3,311
-769
-19% -$1M ﹤0.01% 2650
2018
Q1
$4.71M Sell
4,080
-878
-18% -$1.16M ﹤0.01% 2651
2017
Q4
$5.88M Buy
4,958
+1,351
+37% +$1.69M ﹤0.01% 2563
2017
Q3
$4.85M Buy
+3,607
New +$3.8M ﹤0.01% 2612

Other funds holding KYNB

Dimensional Fund Advisors's KYNB Position: Q2 2023 in Review

Dimensional Fund Advisors sold out of Kyntra Bio (KYNB) in Q2 2023, closing a stake of 3,441 shares — an estimated $1.61M sold.

Dimensional Fund Advisors first reported a position in KYNB in Q3 2017 and held it in 22 quarters. The position peaked at $23.3M in Q2 2020. 152 funds tracked by Wall St. Rank hold KYNB as of Q2 2023.

  • Dimensional Fund Advisors reported no remaining Kyntra Bio position as of Q2 2023 after selling out during the quarter.
  • Dimensional Fund Advisors sold 3,441 Kyntra Bio shares in Q2 2023, an estimated $1.61M.
  • Dimensional Fund Advisors first reported a position in Kyntra Bio in Q3 2017 and held it in 22 quarters.
  • Dimensional Fund Advisors's Kyntra Bio position peaked at $23.3M in Q2 2020.
  • 152 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2023.

Based on Dimensional Fund Advisors's 13F filing for Q2 2023, filed 9 Aug 2023.